Neurorehabilitation Research – barriers and opportunities – future perspectives. Seminar med Julie Bernhardt
Forside / Mødekalender / Neurorehabilitation Research – barriers and opportunities – future perspectives. Seminar med Julie Bernhardt

10/04/2018 - 10/04/2018

Invitation til seminar med Professor, BAppSci (Physio), PhD Julie Bernhardt tirsdag d. 10. April kl. 13-15, auditorie A (ved Hovedindgangen) på Glostrup Hospital – Rigshospitalet, Valdemar Hansens Vej 1-23.

Titel: “Neurorehabilitation Research – barriers and opportunities – future perspectives”

På seminaret vil Julie Bernhardt præsentere The AVERT trial og derefter forelæse om udfordringer og muligheder indenfor fremtidig rehabiliteringsforskning. Der er i de seneste årtier sket en betydelig udvikling indenfor dette forskningsfelt, hvilket har ført til øget viden om effekt af både motorisk, kognitiv og kommunikativ rehabilitering. Der er dog fortsat mange ubesvarede spørgsmål og bl.a. behov for større studier, der kan give os svar på grundlæggende spørgsmål om, hvornår indsatser skal i iværksættes, hvor ofte, hvor længe og hvor intensivt, der skal trænes for at indsatser har effekt.

Julie Bernhardt har gjort sig international bemærket ved at lede the AVERT trail. Der er tale om et af de største og mest veltilrettelagte multicenterstudie af effekt af tidligt fysisk rehabilitering. På seminaet på Glostrup vil Julie Bernhard bl.a. komme ind på nogle af de metodologiske og organisatoriske udfordringer vi står overfor, når vi arbejder med klinisk rehabiliteringsforskning og komme med bud på, hvordan disse barrierer kan overkommes i fremtidig forskning.

Målgruppen for seminaret er, læger, terapeuter, neuropsykologer, sygeplejersker og logopæder, der er interesseret udviklingsarbejde og forskning indenfor neurorehabilitering.

Sprog: Engelsk.

Deltagelse er gratis. Deltagerantallet er begrænset til 30 - så tilmeld dig hurtigt!

Tilmelding sker ved at sende en mail til : hybf@regionh.dk

Seminaret er arrangeret og støtte af: Dansk Selskab for Apopleksi, Dansk Selskab for Neurorehabilitering og Re- connect - Center for hjerneskaderehabilitering, Rigshospitalet – Glostrup.

Julie Bernhardts besøg i Danmark er i øvrigt finansieret af Danske Fysioterapeuter.

 

BIOGRAPHY

Professor Julie Bernhardt

BAppSci (Physio), PhD

·         Senior Principal Florey Research Fellow, The Florey Institute of Neuroscience and Mental Health, Heidelberg, Australia

·         National Health and Medical Research Council (NHMRC) Senior Research Fellow

·         Director, NHMRC Centre for Research Excellence (CRE) Stroke Rehabilitation and Brain Recovery

·         Co-Head, Stroke Division, The Florey Institute of Neuroscience and Mental Health

·         Head, AVERT Early Intervention Research Program, Stroke Division, The Florey Institute of Neuroscience and Mental Health, Austin Health.

 

Professor Julie Bernhardt has worked for over 30 years in the field of stroke, first as a physiotherapist, then later as a clinician researcher.  Julie is a Senior Principal Research Fellow, Co-head of the Stroke Division, and Deputy Director of The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia. She also directs the National Health and Medical Research Council (NHMRC) Centre of Research Excellence (CRE) Stroke Rehabilitation & Brain Recovery, a collaborative research program of eminent stroke researchers from The Florey, Hunter Medical Research Institute (Newcastle, Australia) and other leading institutes.

 

Julie’s research is focused on development and testing of new interventions that aim to improve outcomes for people with stroke. She has been awarded 28 prizes and distinctions, including being named the 2016 winner of the Global category in the Top 100 Women of Influence Awards in Australia. Known best for being Principal Investigator for the international AVERT early rehabilitation trial that ran in 5 countries (Australia, New Zealand, Malaysia, Singapore and the UK) and included over 2000 patients, Julie loves large, complex trials. She has received >60 grants (28 as primary) totalling over $36 million. She was recently awarded a prestigious NHMRC project grant. The results of this trial will provide the first level one evidence for the specific dose of mobilisation to improve outcome for people with stroke.